103
Views
4
CrossRef citations to date
0
Altmetric
Research Article

An evaluation of the cost-effectiveness of duloxetine as a treatment for women with moderate-to-severe stress urinary incontinence

, MSc, , MSc & , MSc
Pages 1-25 | Accepted 07 Jan 2006, Published online: 01 Dec 2008

References

  • Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Neurourology and Urodynamics 2002; 21: 167–178.
  • Bump RC, Copeland Jr WE, Hurt WG et al. Dynamic urethral pressure/profilometry pressure transmission ratio determinations in stress-incontinent and stress-continent subjects. American Journal of Obstetrics and Gynecology 1988; 159: 749–755.
  • Hunskaar S, Lose G, Sykes D et al. The prevalence of urinary incontinence in women in four European countries. BJU International 2004; 93: 324–330.
  • Seim A, Sandvik H, Hermstad R et al. Female urinary incontinence — consultation behaviour and patient experiences: an epidemiological survey in a Norwegian community. Family Practice 1995; 12: 18–21.
  • Shaw C, Tansey R, Jackson C et al. Barriers to help seeking in people with urinary symptoms. Family Practice 2001; 18: 48–52.
  • Shaw C, Das Gupta R, Dallosso H et al. The current extent and impact of stress urinary incontinence symptoms in women who had previously sought help with a healthcare professional (Abstract). Presented at International Continence Society — UK Conference; Leicester, UK; 2003 April 24–25.
  • Hay-Smith EJ, Bo Berghmans LC, Hendriks HJ et al. Pelvic floor muscle training for urinary incontinence in women. Cochrane Database of Systematic Reviews 2001; 1:CD001407.
  • Wilson PD, Bø K, Hay-Smith J et al. Conservative treatment in women. In: Abrams P, Shoury S, Wein A, Editors. Incontinence, 2nd edn. Plymouth, UK: Health Publication Ltd., 2002: 571–624.
  • Lagro-Janssen T, Van Weel C. Long-term effect of treatment of female incontinence in general practice. British Journal of General Practice 1998; 48: 1735–1738.
  • Adams EJ, Barrington JW, Brown K et al. Surgical treatment of urodynamic stress incontinence. Royal College of Obstetricians and Gynaecologists Guideline No. 35, October 2003. Available at: http://www.rcog.org.uk/ index.asp? PageID=15 (accessed 4 April 2004).
  • Health Research Unit and Health Economics Research Unit, University of Aberdeen. Systematic review of the clinical effectiveness and cost-effectiveness of tension-free vaginal tape (TVT) for treatment of urinary stress incontinence. Report commissioned by NHS R&D HTA Programme on behalf of The National Institute for Clinical Excellence. Available at: http://www.nice.org.uk/pdf/ Assessment_report_TVT.pdf (accessed 7 May 2004).
  • Black NA, Downs SH. The effectiveness of surgery for stress incontinence in women: a systematic review. British Journal of Urology 1996; 78: 497–510.
  • Diokno AC, Burgio K, Fultz NH et al. The prevalence and outcomes of continence surgery among community-dwelling women. Journal of Urology 2003; 170: 507–511.
  • Bump R, Hooper C, Koke S et al. Worldwide efficacy of duloxetine after 12 weeks and 1 year in women with stress urinary incontinence (SUI): a 4-study meta-analysis. Poster presented at 33rd annual meeting of the International Continence Society (ICS); Florence, Italy; 5–9 October 2003 [Abstract 337]. Available at: http://www.continet.org/ publications /2003/pdf/337.pdf (accessed 15 April 2004).
  • Norton P, Zinner NR, Yalcin I et al. Duloxetine versus placebo in the treatment of stress urinary incontinence. American Journal of Obstetrics and Gynecology 2002; 187: 40–48.
  • Dmochowski RR, Norton PA, Zinner NR et al. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence. Journal of Urology 2003; 170: 1259–1263.
  • Van Kerrebroeck P, Abrams P, Lange R et al. Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence. British Journal of Obstetrics and Gynaecology 2004; 111: 249– 257.
  • Millard RJ, Moore K, Rencken R et al. Duloxetine versus placebo in the treatment of stress urinary incontinence: a four-continent randomised clinical trial. BJU International 2004; 93: 311–318.
  • Ghoniem G, Van Leeuwen JS, Elser DM et al. A randomised controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence. Journal of Urology 2005; 173: 1647–1653.
  • Kinchen KS, Obenchain R, Swindle R. The impact of duloxetine on quality of life for women with symptoms of urinary incontinence. International Urogynecology Journal and Pelvic Floor Dysfunction 2005; 16: 337–344.
  • Data on file. Eli Lilly and Company Ltd.
  • Department of Health. Good Practice in Continence Services. London, UK: Department of Health, 2000.
  • Scottish Intercollegiate Guidelines Network. Management of urinary incontinence in primary care, 2005. Available at http://www. sign.ac.uk/guidelines/published/ (accessed 28 June 2005).
  • National Institute for Health and Clinical Excellence. Urinary incontinence: the management of urinary incontinence in women. Guidelines and cancer service guidance in development. Available at: http:// www.nice.org.uk/page.aspx?o=guidelines. inprogress (accessed 1 July 2005).
  • Data on file: Moderate to Severe Patients in the Meta-analysis Studies. Eli Lilly & Company Ltd. and Boehringer Ingelheim, 2005.
  • Ward K, Hilton P; United Kingdom and Ireland Tension-free Vaginal Tape Trial Group. Prospective multicentre randomised trial of tension-free tape and colposuspension as primary treatment for stress incontinence. BMJ 2002; 325: 67–73.
  • Wagg AS, Bushnell D, Das Gupta RJ. Treatments received for stress urinary incontinence (SUI) symptoms by patients referred to secondary care within a UK setting. Poster presented at the International Continence Society (UK); Bournemouth, UK; 19 March 2004.
  • Department of Health. Hospital Episode Statistics. Health and Social Care Information Centre, 2003/2004.
  • Kinchen KS, Obenchain R, Swindle R. Impact of duloxetine on quality of life for women with symptoms of urinary incontinence. International Urogynecology Journal and Pelvic Floor Dysfunction 2005; 16: 337–344.
  • Manikandan R, Kujawa M, Pearson E et al. Results of the tension-free vaginal tape procedure for stress incontinence: patient’s perspective. International Journal of Urology 2004; 11: 206–212.
  • Kobelt G. Economic considerations and outcome measurement in urge incontinence. Urology 1997; 50 (Suppl 6A): 100–107.
  • Manca A, Sculpher MJ, Ward K et al. A cost– utility analysis of tension-free tape versus colposuspension for primary urodynamic stress incontinence. British Journal of Obstetrics and Gynaecology 2003; 110: 255– 262.
  • Das Gupta R, Wagg A, Porkess S et al. A description of the healthcare provision received by women with urinary incontinence seeking help for their symptoms in the UK and Republic of Ireland. ICS (UK) 12th Annual Scientific Meeting; Glasgow, UK; 31 March – 1 April 2005.
  • Yentreve Summary of Product Characteristics; November 2005.
  • Lalos O. Quality of life: a Marshall–Marchetti– Krantz procedure for stress urinary incontinence. Journal of Urology 1996; 155: 259–262.
  • McAllister R, Das Gupta R, Piercy J et al. An analysis of patients on waiting lists to receive surgery for stress urinary incontinence (SUI) in England and Scotland. Presented at the International Society for Pharmacoeconomic and Outcomes Research; Hamburg, Germany; 24–26 October 2004.
  • NHS Reference Costs, 2004. Available at: http://www.doh.gov.uk (accessed 7 December 2005).
  • Personal Social Services Research Unit. Unit Costs of Health & Social Care, 2004.
  • MIMS. July 2005.
  • National Institute for Clinical Excellence. Guide to the methods of technology appraisal, April 2004. Available at: http:// www.nice.org.uk (accessed 17 March 2005).
  • Lalos O, Berglund AL, Lalos A. Impact of urinary and climacteric symptoms on social and sexual life after surgical treatment of stress urinary incontinence in women: a long- term outcome. Journal of Advanced Nursing 2001; 33: 316–327.
  • Black N, Griffiths J, Pope C et al. Impact of surgery for stress incontinence on morbidity: cohort study. BMJ 1997; 315: 1493–1502.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.